中
Home
About TUL
Group Introduction
Executive Directors
Subsidiaries
Contact Us
Innovation in R&D
R&D Pipeline
R&D Platform
R&D Updates
News
TUL Highlights
Product Center
Finished Products
Comprehensive Health Products
APIs and Intermediates
Animal protection products
Empty capsule
Medical device
Cosmetic Peptide Series
Sustainability
Enhancing Governance
Normalizing Healthiness
Brand Building
People-Oriented
Green Development
ESG Reports
ESG News
Investor Relations
News
TUL Highlights
2026-07-15
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION
Learn More
2026-07-03
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT TADALAFIL TABLETS
Learn More
2026-06-22
Tsoi Hoi Shan Attended Novo Nordisk Roundtable to Discuss the Global Impact of Chinese Innovation
Learn More
2026-06-12
APPROVAL FOR CLINICAL TRIAL OF THE GROUP’S PRODUCT TUL321 CAPSULES
Learn More
2026-05-20
APPROVAL FOR CLINICAL TRIAL OF GROUP’S PRODUCT TUL108 FOR INJECTION
Learn More
All News
Select Year
2026
2025
2024
TUL Releases 2023 ESG Report
2024-04-08
Zhuhai United Laboratories Co., Ltd. Passes Brazilian GMP Inspection
2024-04-01
Hitting A New Record High! TUL’s Annual Revenue Exceeds RMB 13.7 Billion in 2023
2024-04-01
The United Animal Healthcare (Inner Mongolia) Co., Ltd. Receives Class V New Veterinary Drug Certificate for Cyclosporine Oral Solution
2024-03-27
Chairman Tsoi Hoi Shan Attends Signing Ceremony Between The United Animal Healthcare (Inner Mongolia) Co., Ltd. and New Zealand’s Riverland Foods
2024-03-20
Beineng An® Passes Generic Drug Consistency Evaluation in Quality and Efficacy
2024-01-18
Prev
1
...
12
13
14
15
16
17
Next
WeChat
Official
Account
To Top
粤公网安备44040402000348号
